50 related articles for article (PubMed ID: 35751777)
1. Body composition changes in patients with differentiated thyroid cancer after iodine-131 treatment and short-term levothyroxine replacement and suppression therapy.
Wang R; Qin S; Qiao T; Jiang W; Tong J; Lu G; Gao D; Zhang M; Lv Z; Li D; Chai L
Hormones (Athens); 2024 Jan; ():. PubMed ID: 38277093
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study.
Brigante G; Santi D; Boselli G; Margiotta G; Corleto R; Monzani ML; Craparo A; Locaso M; Sperduti S; Roy N; Casarini L; Trenti T; Tagliavini S; De Santis MC; Roli L; Rochira V; Simoni M
Eur J Endocrinol; 2024 Jan; 190(1):12-22. PubMed ID: 38124252
[TBL] [Abstract][Full Text] [Related]
3. Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).
Ho AL; Dedecjus M; Wirth LJ; Tuttle RM; Inabnet WB; Tennvall J; Vaisman F; Bastholt L; Gianoukakis AG; Rodien P; Paschke R; Elisei R; Viola D; So K; Carroll D; Hovey T; Thakre B; Fagin JA;
J Clin Oncol; 2022 Jun; 40(17):1870-1878. PubMed ID: 35192411
[TBL] [Abstract][Full Text] [Related]
4. Radioactive Iodine in Differentiated Thyroid Carcinoma: A Systematic AGREE II Clinical Practice Guideline Appraisal.
Monos S; Fritz C; Harris J; Romeo D; Ng JJ; Xu K; Cooperberg B; Moreira A; Rajasekaran K
Otolaryngol Head Neck Surg; 2024 Jan; 170(1):20-33. PubMed ID: 37694597
[TBL] [Abstract][Full Text] [Related]
5. Association of radioactive iodine treatment in differentiated thyroid cancer and cardiovascular death: a large population-based study.
Zhang H; Xie H; Li L
J Endocrinol Invest; 2024 Feb; 47(2):443-453. PubMed ID: 37543985
[TBL] [Abstract][Full Text] [Related]
6. The Use of Levothyroxine Absorption Tests in Clinical Practice.
Caron P; Declèves X
J Clin Endocrinol Metab; 2023 Jul; 108(8):1875-1888. PubMed ID: 36916146
[TBL] [Abstract][Full Text] [Related]
7. Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001-2018.
Dal Maso L; Pierannunzio D; Francisci S; De Paoli A; Toffolutti F; Vaccarella S; Franceschi S; Elisei R; Fedeli U
Eur Thyroid J; 2023 Jul; 12(4):. PubMed ID: 37256604
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Nonrandomized Controlled Trial Examining the Use of Artificial Tears on the Radioactivity of Tears After Radioactive Iodine Treatment for Thyroid Cancer.
Lee IT; Grice JV; Ji X; Chen Q; Bischoff LA; Jessop AC; Barahimi B; Codere F; Mawn LA; Sobel RK
Thyroid; 2024 Jan; 34(1):82-87. PubMed ID: 37917111
[No Abstract] [Full Text] [Related]
9. Prophylactic effect of pilocarpine on acute sialadenitis following radioactive iodine therapy in thyroid cancer patients.
Choi EK; Oh JK; Chung YA; Jeong H; Choi H; Jo K
Int J Med Sci; 2024; 21(3):492-495. PubMed ID: 38250604
[No Abstract] [Full Text] [Related]
10. Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study.
Kim MS; Lee JW; Hyun MK; Song YS
Endocrinol Metab (Seoul); 2024 Apr; 39(2):288-299. PubMed ID: 38437824
[TBL] [Abstract][Full Text] [Related]
11. Effects of radioactive iodine on clonal hematopoiesis in patients with thyroid cancer: A prospective study.
Boucai L; Ptashkin RN; Levine RL; Fagin JA
Clin Endocrinol (Oxf); 2023 Jul; 99(1):122-129. PubMed ID: 37088956
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer.
Balakirouchenane D; Seban R; Groussin L; Puszkiel A; Cottereau AS; Clerc J; Vidal M; Goldwasser F; Arrondeau J; Blanchet B; Huillard O
Thyroid; 2023 Nov; 33(11):1327-1338. PubMed ID: 37725566
[No Abstract] [Full Text] [Related]
13. Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
Gianoukakis AG; Choe JH; Bowles DW; Brose MS; Wirth LJ; Owonikoko T; Babajanyan S; Worden FP
Eur Thyroid J; 2024 Feb; 13(1):. PubMed ID: 38096102
[TBL] [Abstract][Full Text] [Related]
14. Using haematological indices to predict impaired liver function in DTC patients.
Zhou Y; Chai H
Hell J Nucl Med; 2024; 27(1):2-7. PubMed ID: 38629813
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Low Adherence to the Low-iodine Diet on the Efficacy of the Radioactive Iodine Ablation Therapy.
Ju DL; Park YJ; Paik HY; Song Y
Clin Nutr Res; 2015 Oct; 4(4):267-71. PubMed ID: 26566522
[TBL] [Abstract][Full Text] [Related]
16. The effect of radioactive iodine treatment for differentiated thyroid cancer on male gonadal function: a meta-analysis.
Cai Y; Yang Y; Pang X; Li S
Endocr Connect; 2023 Dec; 12(12):. PubMed ID: 37855387
[TBL] [Abstract][Full Text] [Related]
17. How Radioactive Iodine Treatment Affects the Retina.
Gürez C; Özen A; Ekmekçioğlu Ö
World J Nucl Med; 2023 Dec; 22(4):257-260. PubMed ID: 38152097
[No Abstract] [Full Text] [Related]
18. Theranostic Risk Stratification for Thyroid Cancer in the Genomic Paradigm.
Gulec SA; Meneses E
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672667
[TBL] [Abstract][Full Text] [Related]
19. Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial.
Marina M; Maglietta G; De Filpo G; Aloe R; Gnocchi C; Iezzi E; Caminiti C; Ceresini G
Endocrine; 2022 Aug; 77(2):340-348. PubMed ID: 35751777
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
